Intrust Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Sell
11,489
-154
-1% -$157K 1.02% 22
2026
Q1
$10.7M Buy
11,643
+190
+2% +$193K 0.87% 20
2025
Q4
$12.3M Sell
11,453
-98
-0.8% -$93.7K 1.02% 21
2025
Q3
$8.81M Sell
11,551
-144
-1% -$107K 0.73% 25
2025
Q2
$9.12M Sell
11,695
-1,026
-8% -$797K 0.81% 23
2025
Q1
$10.5M Sell
12,721
-220
-2% -$183K 1.04% 20
2024
Q4
$9.99M Sell
12,941
-414
-3% -$343K 1.01% 22
2024
Q3
$11.8M Sell
13,355
-39
-0.3% -$35.1K 1.18% 16
2024
Q2
$12.1M Sell
13,394
-469
-3% -$375K 1.29% 15
2024
Q1
$10.8M Sell
13,863
-504
-4% -$359K 1.16% 16
2023
Q4
$8.37M Sell
14,367
-203
-1% -$118K 0.97% 16
2023
Q3
$7.83M Sell
14,570
-145
-1% -$74.7K 1% 16
2023
Q2
$6.9M Sell
14,715
-1,399
-9% -$587K 0.84% 18
2023
Q1
$5.53M Buy
16,114
+2,008
+14% +$677K 0.71% 21
2022
Q4
$5.16M Buy
14,106
+497
+4% +$176K 0.72% 24
2022
Q3
$4.4M Buy
13,609
+83
+0.6% +$26.3K 0.68% 24
2022
Q2
$4.39M Buy
13,526
+158
+1% +$47.4K 0.63% 27
2022
Q1
$3.83M Buy
13,368
+283
+2% +$72.8K 0.48% 35
2021
Q4
$3.62M Sell
13,085
-16
-0.1% -$4.06K 0.44% 38
2021
Q3
$3.03M Buy
13,101
+129
+1% +$31.8K 0.4% 40
2021
Q2
$2.98M Buy
12,972
+503
+4% +$101K 0.4% 40
2021
Q1
$2.33M Sell
12,469
-79
-0.6% -$15.5K 0.34% 54
2020
Q4
$2.12M Sell
12,548
-442
-3% -$66K 0.32% 64
2020
Q3
$1.92M Sell
12,990
-64
-0.5% -$9.9K 0.34% 64
2020
Q2
$2.14M Buy
13,054
+342
+3% +$52.5K 0.43% 49
2020
Q1
$1.76M Buy
12,712
+896
+8% +$123K 0.49% 45
2019
Q4
$1.55M Buy
11,816
+61
+0.5% +$7.07K 0.35% 66
2019
Q3
$1.31M Sell
11,755
-689
-6% -$76.7K 0.33% 70
2019
Q2
$1.38M Buy
12,444
+1,198
+11% +$141K 0.34% 64
2019
Q1
$1.46M Buy
11,246
+208
+2% +$25.3K 0.37% 61
2018
Q4
$1.28M Buy
11,038
+337
+3% +$37.6K 0.37% 62
2018
Q3
$1.15M Buy
10,701
+852
+9% +$85.2K 0.29% 75
2018
Q2
$840K Buy
9,849
+597
+6% +$49K 0.23% 107
2018
Q1
$716K Sell
9,252
-254
-3% -$20.4K 0.21% 124
2017
Q4
$803K Buy
9,506
+646
+7% +$55K 0.24% 118
2017
Q3
$758K Buy
8,860
+590
+7% +$48.4K 0.25% 118
2017
Q2
$681K Sell
8,270
-39
-0.5% -$3.18K 0.23% 122
2017
Q1
$699K Buy
8,309
+472
+6% +$37.8K 0.25% 114
2016
Q4
$576K Buy
7,837
+338
+5% +$25.2K 0.22% 140
2016
Q3
$602K Buy
7,499
+331
+5% +$26.5K 0.24% 131
2016
Q2
$564K Buy
7,168
+2,309
+48% +$174K 0.23% 138
2016
Q1
$350K Sell
4,859
-86
-2% -$6.51K 0.13% 197
2015
Q4
$417K Sell
4,945
-63
-1% -$5.23K 0.16% 174
2015
Q3
$419K Sell
5,008
-76
-1% -$6.42K 0.16% 166
2015
Q2
$424K Sell
5,084
-359
-7% -$27.4K 0.15% 178
2015
Q1
$395K Sell
5,443
-1,646
-23% -$117K 0.14% 183
2014
Q4
$489K Sell
7,089
-181
-2% -$12.2K 0.18% 153
2014
Q3
$472K Buy
7,270
+6
+0.1% +$380 0.18% 157
2014
Q2
$451K Sell
7,264
-4,389
-38% -$262K 0.17% 170
2014
Q1
$685K Buy
11,653
+1,528
+15% +$85.3K 0.28% 107
2013
Q4
$516K Buy
10,125
+4,766
+89% +$239K 0.22% 139
2013
Q3
$270K Sell
5,359
-2,674
-33% -$140K 0.13% 206
2013
Q2
$394K Buy
+8,033
New +$437K 0.17% 184

Other funds holding LLY

Intrust Bank's LLY Position: Q2 2026 in Review

Intrust Bank reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $157K and leaving 11,489 shares worth $13.8M. The position accounts for 1.02% of the portfolio, ranked #22.

Intrust Bank first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Intrust Bank held 11,489 shares of Eli Lilly worth $13.8M as of Q2 2026.
  • Intrust Bank sold 154 Eli Lilly shares in Q2 2026, an estimated $157K.
  • Eli Lilly made up 1.02% of Intrust Bank's portfolio in Q2 2026, its #22 holding.
  • Intrust Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.